Sangamo Therapeutics Inc reports results for the quarter ended in June - Earnings Summary

Sangamo Therapeutics

08/08/2023 22:01

* Sangamo Therapeutics Inc  SGMO.OQ  reported a quarterly
adjusted
loss of 66 cents​​ per share for the quarter ended in June. The
mean expectation of eleven analysts for the quarter was for a
loss of 34 cents per share.
    * Revenue fell 76.7% to $6.84 million from a year ago;
analysts
expected $14.83 million. 
    * The mean earnings estimate of analysts had fallen by
about 1.9%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Sangamo Therapeutics Inc shares had fallen by 10.0% this
quarter and lost 62.7% so far this year.
    * Wall Street's median 12-month price target for Sangamo
Therapeutics Inc is $8.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 8 "strong buy" or "buy," 2
"hold" and 1 "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 8 at 09:00 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -0.34          -0.66          Missed
 Mar. 31 2023      -0.33          0.12           Beat
 Dec. 31 2022      -0.36          -0.32          Beat
 Sep. 30 2022      -0.36          -0.34          Beat